Shares of ImmuPharma Plc (LON: IMM) today fell 26% after the company revealed that it had raised £6.5 million through a discounted share placement.
The firm sold over 59 million shares at 11p each, which is a 27.6% discount to yesterday’s closing price of 16.50p.
The company’s share price fell as existing investors complained about the huge discount at which the shares were placed, and why the offer was only made available to institutional investors.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
It does not make business sense for a company to sell its shares at such a huge discount, especially if they end up being oversubscribed, which indicates that there could be sufficient demand for the shares near current prices.
The management intends to use the proceeds of the share placement to advance its therapeutic pipeline, particularly the development of BioAMP-B, a peptide-based drug targeted at life-threatening fungal infections such as aspergillosis (lung infection).
ImmuPharma shares have lost over 90% of their value since hitting all-time highs of 193p in January 2018 and it unlikely they will reach such highs any time soon.
ImmuPharma share price
ImmuPharma shares today fell 26% from yesterday’s closing price of 16.50p to a low of 12.20p.
